RP1 in Primary Melanoma to Reduce the Risk of Sentinel Lymph Node Metastasis
Clinical trial NCT06216938 · RECRUITING
Trial details
- NCT number
- NCT06216938
- Sponsor
- Yana Najjar
- Status
- RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-03-07
- Primary completion
- 2028-03-31
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.